Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis

Size: px
Start display at page:

Download "Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis"

Transcription

1 CHEST Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis Original Research Natalie E. West, MD, MHS; Noah Lechtzin, MD, MHS, FCCP; Christian A. Merlo, MD, MPH; Jason B. Turowski, MD; Marsha E. Davis, MPH; Meghan Z. Ramsay, CRNP; Sharon L. Watts, RN; Shane P. Stenner, MD; and Michael P. Boyle, MD, FCCP CYSTIC FIBROSIS Background: Vitamin D deficiency is common in patients with cystic fibrosis (CF), and guidelines recommend 25-hydroxyvitamin D (25OHD) levels 30 ng/ml. This threshold was selected because serum parathyroid hormone (PTH) rises in healthy individuals when the 25OHD level falls below 30 ng/ml. PTH levels. 50 pg/ml are associated with an increased risk of bone loss. However, the relationship between 25OHD and PTH has not been studied in CF. We sought to determine the appropriate goal 25OHD level in patients with CF by identifying the level below which the risk of PTH. 50 pg/ml begins to increase. Methods: Levels of 25OHD and PTH in 216 individuals with CF were collected prospectively. Individuals with 25OHD, 30 ng/ml were treated with vitamin D2, and levels were reevaluated. Results: Mean 25OHD level was ng/ml, and mean PTH level was pg/ml. In 63% of individuals, 25OHD level was, 30 ng/ml, and in 38.0% it was 20 ng/ml. Low 25OHD levels were significantly associated with elevated PTH levels, with a mean PTH of pg/ml for 25OHD level 0 to 19 ng/ml; pg/ml for 25OHD level 20 to 29 ng/ml; pg/ml for 25OHD level 30 to 39 ng/ml; and pg/ml for 25OHD level 40 ng/ml ( P 5.006). We assessed the sensitivity of different 25OHD thresholds to identify individuals meeting the goal of a PTH level, 50 pg/ml to reduce the risk of bone loss. To obtain 90% sensitivity, a 25OHD level 35 ng/ml was required. Strikingly, 23% of individuals with 25OHD levels 30 to 34 ng/ml still had a PTH level. 50 pg/ml. This decreased to 14% for 25OHD level 35 ng/ml. Conclusions: Inadequate serum 25OHD levels are common in adults with CF and are associated with elevated PTH levels. Aiming to maintain 25-OHD levels 35 ng/ml in individuals with CF decreases the risk of having a PTH level associated with secondary hyperparathyroidism and bone loss. CHEST 2011; 140(2): Abbreviations: 1,25OH 2 D 5 1,25-dihydroxyvitamin D; 25OHD 5 25-hydroxyvitamin D; CF 5 cystic fibrosis; CFF 5 Cystic Fibrosis Foundation; PTH 5 parathyroid hormone Cystic fibrosis (CF) is characterized by chronic pulmonary infections, sinus disease, pancreatic insufficiency, male infertility, cystic fibrosis-related diabetes, and osteoporosis. 1 Over the past sev eral decades, median predicted survival has improved from 16 years of age in 1970 to. 37 years currently.2 Decreased bone mineral density and increased risk of fracture are common complications in CF. 1 Multiple studies have reported that 50% to 75% of adults with CF have low bone density, 1 with approximately 20% to 25% having osteoporosis and 40% having osteopenia. 3 Multiple factors contribute to this increased risk of osteoporosis, including malnutrition, vitamin D deficiency, inadequate absorption of calcium, physical inactivity, and glucocorticoid use. 1 Additionally, the prevalence of vitamin D insufficiency in individuals with CF is significantly higher when compared with healthy control subjects, most likely secondary to malabsorption of fat-soluble vitamins resulting from pancreatic insufficiency, poor nutrition, and low exposure to sunlight. 4 Vitamin D is obtained from sunlight by the skin and converted from 7-dehydrocholesterol to cholecalciferol (vitamin D3) or absorbed from the diet CHEST / 140 / 2 / AUGUST,

2 and converted from ergosterol to ergocalciferol (vitamin D2). Both are then converted in the liver to 25-hydroxyvitamin D (25OHD). 25OHD is the major storage form of vitamin D and is measured clinically to assess adequacy of vitamin D stores. 5 25OHD is then converted by the kidney to its active form, 1,25-dihydroxyvitamin D (1,25OH 2 D), which maintains calcium homeostasis. 1 Low vitamin D levels, defined as 25OHD levels, 30 ng/ml, are common in individuals with CF regardless of season or latitude. 1 The threshold of 30 ng/ml was selected because levels below this in individuals without CF lead to a rise in serum parathyroid hormone (PTH). 6 Elevated PTH levels are strongly associated with increased bone resorption and resultant bone loss, particularly PTH levels. 50 pg/ml. 1,6-10 Guidelines from the Cystic Fibrosis Foundation s (CFF s) Consensus Conference on Bone Health recommend that vitamin D2 supplementation be given to maintain 25OHD levels 30 ng/ml. 1 However, the 25OHD threshold at which PTH begins to rise in CF has not been determined. It is unclear whether a goal level of 30 ng/ml is appropriate for CF, particularly given the multiple challenges encountered when attempting to maintain individuals with CF at this level. Therefore, the purpose of this investigation was to determine the appropriate therapeutic 25OHD level in individuals with CF by determining the threshold below which there is an increased risk of elevated PTH levels. 50 pg/ml. Serum 25OHD values were determined at a single Quest Diagnostics laboratory (Teterboro, New Jersey) using liquid chromatography-tandem mass spectroscopy. Serum PTH levels were determined in a single hospital laboratory using two-site sandwich immunoassay PTH on the Elecsys 2010 platform (Roche Diagnostics; Indianapolis, Indiana). Per CFF guidelines, adults at the Johns Hopkins CF Program have 25OHD levels measured annually. 1 Individuals also have annual PTH, 1,25OH 2 D, and calcium levels measured. As described in an earlier publication, 3 individuals with 25OHD levels, 30 ng/ml are routinely treated with vitamin D2 50,000 International Units po daily for 30 days, and 25OHD and PTH levels are reevaluated 2 weeks thereafter. Statistical Analysis Summary statistics were calculated, and data are presented as appropriate by means SD, medians and interquartile range, or proportions. Graphical analyses were performed using scatterplots and histograms. The Shapiro-Wilk W test was used to check for normality. Means were compared using paired and unpaired t tests where appropriate. The Kruskal-Wallis test or analysis of variance was used to compare means of three or more groups. Proportions were compared using x 2 or Fisher exact test. Logistic regression was used to assess the association between 25OHD and PTH. We calculated the sensitivity and specificity of different 25OHD values to predict elevated PTH levels. These calculations were made using a threshold value of PTH. 50 pg/ml, because review of the literature demonstrates increased risk of bone density loss above this level. 8,9,11-13 Analysis was also performed using a definition of. 75 pg/ml as the threshold for elevated PTH level to assure similar results were obtained. Statistical significance was set at P,.05 for all analyses. Analyses were performed using STATA 10.0 (StataCorp; College Station, Texas). Materials and Methods This was a cohort study in which we collected data on all individuals seen at the Johns Hopkins Adult CF Clinic from January 2004 through January 2009 who had 25OHD and PTH (nonfasting) levels drawn. 1,25OH 2 D and calcium levels were also recorded. Individuals with HIV, chronic renal insufficiency, and organ transplant were excluded, as these disease processes are known to affect PTH levels and vitamin D status. This study was approved by the Johns Hopkins University School of Medicine institutional review board (protocol e). Manuscript received August 16, 2010; revision accepted January 14, Affiliations: From the Division of Pulmonary and Critical Care Medicine, Department of Medicine (Drs West, Lechtzin, Merlo, and Boyle and Mss Ramsay and Watts), and the Department of Nutrition (Ms Davis), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary and Critical Care Medicine, Department of Medicine (Dr Turowski), University of Pennsylvania, Philadelphia, PA; and the Department of Medicine (Dr Stenner), Vanderbilt University, Nashville, TN. Funding/Support: The authors have reported to CHEST that no funding was received for this study. Correspondence to: Natalie E. West, MD, MHS, 1830 E Monument St, 5th Floor, Baltimore, MD 21205; nwest5@jhmi.edu. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( site/misc/reprints.xhtml ). DOI: /chest Results Two hundred sixteen individuals with CF were included in this study, and their demographics are summarized in Table 1. Twenty-one individuals with HIV, chronic renal insufficiency, or lung transplant were excluded. Of the 216 individuals, 136 (63.0%) had 25OHD levels below the currently recommended 30 ng/ml. Fifty-four (25.0%) were vitamin D insufficient (25OHD level, ng/ml), and 82 (38.0%) were vitamin D deficient (25OHD level 20 ng/ml). Eighty individuals (37.0%) were vitamin D sufficient (25OHD level 30 ng/ml), with 50 (23.1%) with 25OHD levels 35 ng/ml. The mean ( SD) 25OHD level was ng/ml (normal ng/ml). The mean PTH level was pg/ml (normal pg/ml). A total of 23.6% of the participants had PTH levels 50 to 74 pg/ml, and 12.5% had levels. 75 pg/ml. No participants had serum calcium levels mg/dl or, 7.2 mg/dl (normal mg/dl). The mean 1,25OH 2 D level was pg/ml (normal pg/ml). We found no correlation between 25OHD and 1,25OH 2 D levels ( P 5.40, test of Ho), consistent with prior reports. 7, Original Research

3 Table 1 Participant Characteristics (N 5 216) Age, y (18-68) Female 107 (49.5) FEV 1, % predicted ( ) BMI, kg/m ( ) delf508/delf508 genotype 100 (46.3) Pancreatic insufficient 182 (84.3) Bone density by DEXA Normal 106 (49.1) Osteopenia 86 (39.8) Osteoporosis 24 (11.1) Mean 25OHD, ng/ml Vitamin D deficient, 20 ng/ml 82 (38.0) Vitamin D insufficient, ng/ml 54 (25.0) Vitamin D sufficient ng/ml 30 (13.9) 35 ng/ml 50 (23.1) Data are presented as No. (%), mean SD, or mean SD (range). 25OHD 5 25-hydroxyvitamin D; DEXA 5 dual energy x-ray absorptiometry. Relationship Between 25OHD and PTH Levels Figure 1 demonstrates the inverse relationship between 25OHD and PTH levels in the study group. The overall correlation between 25OHD and PTH level was r , P Low vitamin D levels were clearly associated with elevated PTH levels, with mean SD (median) PTH values being (51) pg/ml for 25OHD levels 0 to 19 ng/ml; (42) pg/ml for 25OHD levels 20 to 29 ng/ml; (36) pg/ml for 25OHD levels 30 to 34 ng/ml; and (34.5) pg/ml for 25OHD levels 40 ng/ml ( Fig 2 ). From the standpoint of a caregiver of a patient with CF, the most important question is at what 25OHD level is PTH, 50 pg/ml, where bone resorp- tion and risk of fracture is decreased? We assessed the sensitivity of different 25OHD thresholds in identifying individuals with PTH levels within the ideal range (, 50 pg/ml). The sensitivity of 25OHD levels to predict a PTH level, 50 pg/ml is shown in Table 2. To obtain 90% sensitivity of having a PTH level, 50 pg/ml in our CF study cohort, a goal 25OHD level of 35 ng/ml was required. Using the 2005 CFF guidelines of a target 25OHD level of 30 ng/ml, % of individuals still had a PTH level associated with increased bone loss (. 50 pg/ml). Strikingly, 23% of the individuals with 25OHD levels 30 to 34 ng/ml had a PTH level. 50. This decreased to 14% for 25OHD levels 35. Effect of Vitamin D Supplementation on PTH Levels in CF Of the 216 individuals who had initial measurements of 25OHD and PTH levels, 140 (65%) had subsequent measurements. We specifically analyzed individuals who were initially vitamin D deficient with 25OHD levels 20 ng/ml to determine the effect of vitamin D2 supplementation on their PTH levels. In these 36 individuals, initial mean ( SD) 25OHD level was ng/ml, and the mean PTH level was pg/ml. All were treated with vitamin D2 50,000 IU po daily for 30 days. Mean 25OHD level after supplementation was ng/ml ( P,.001), and mean PTH level decreased significantly to pg/ml, ( P 5.05). Twenty (56.6%) had PTH levels. 50 pg/ml before treatment, whereas only seven (19.4%) individuals had a PTH level. 50 pg/ml afterward. One important observation, however, was that correcting vitamin D deficiency was not long-lived. Eighteen of the 36 corrected individuals subsequently became vitamin D insufficient again within 1 year. At a mean of months, mean ( SD) 25OHD level decreased from to ng/ml ( P ). The protocol at our CF clinic is to check 25OHD and PTH levels 2 weeks after supplementation with vitamin D2 as above and then yearly thereafter. Therefore, it is possible deficiency occurred earlier, but the exact time course of becoming vitamin D deficient again could not be calculated. During the study period, maintenance therapy was standard CF vitamins, which included 800 to 1,000 International Units of cholecalciferol (D3) daily. Figure 1. Relationship between 25OHD and PTH levels. Scatterplot of the relationship between all 25OHD and PTH levels in the study group. The overall correlation was r , P Low 25OHD levels are associated with elevated PTH levels. 25OHD 5 25-hydroxyvitamin D; PTH 5 parathyroid hormone. Discussion The recognition of osteoporosis and vitamin D deficiency as significant problems in individuals with CF has led to increased efforts to optimize vitamin D CHEST / 140 / 2 / AUGUST,

4 Figure 2. Quartiles of 25OHD levels and correlating PTH levels. Low 25OHD levels are significantly associated with elevated serum PTH levels. Twenty-three percent of the individuals with 25OHD levels 30 to 34 ng/ml had a PTH. 50. This decreased to 14% for 25OHD levels 35. At serum 25OHD levels between 30 and 39 ng/ml, 19% of patients still have PTH levels. 50 pg/ml. Lower and upper hinge of each box plot represents the 25th and 75th percentiles, respectively, with the median value represented as a bold line within each box. The whiskers are drawn to the smallest and largest observations that fall within 1.5 times the interquartile range, with outliers represented as outside of these values. See Figure 1 legend for expansion of abbreviations. and calcium metabolism. These efforts include the 2005 CFF Consensus on Bone Health Guidelines, which recommend that individuals with CF receive vitamin D2 supplementation to maintain their 25OHD level 30 ng/ml. 1 However, this recommendation was based on the relationship between 25OHD and PTH levels in individuals without CF. To our knowledge, our study is the first to specifically examine the relationship between 25OHD and PTH in individuals with CF. It confirms the well-documented high prevalence of vitamin D deficiency in CF but has the key finding that caregivers of patients with CF should likely be aiming to correct 25OHD levels to. 35 ng/ml. Table 2 Sensitivity of 25OHD Levels for Suppressing PTH Levels to, 50 pg/ml 25OHD Cut Point Sensitivity, % PTH 5 parathyroid hormone. See Table 1 legend for expansion of other abbreviation. Correction to 35 ng/ml results in a greater likelihood of suppressing PTH levels below those associated with increased bone loss. There is currently much discussion of what constitutes a normal 25OHD level, even in healthy individuals. Most experts agree that a 25OHD level 20 ng/ml is consistent with vitamin D deficiency, and a 25OHD level of 21 to 29 ng/ml is considered vitamin D insufficiency. 14 The most commonly accepted range of normal 25OHD level is 32 to 100 ng/ml. 14 However, it is uncertain what the optimal 25OHD level should be, as this range is based on obtaining blood from several hundred healthy volunteers and assigning the normal range as the mean 2 SDs. It is now known that 30% to 50% of the US and European population is vitamin D deficient or insufficient, which may have resulted in skewing of the normal range. 14 One physiologic method to determine optimal 25OHD level is to evaluate its effect on PTH, which increases in response to perceived calcium insufficiency. The most cited study of this relationship concluded that PTH begins a significant increase in value in individuals without CF when 25OHD levels drop to, 30 ng/ml. 6 Yet, there is interindividual variability in this relationship, and similar to our study, 20% of the individuals with 25OHD levels between 30 and 34 ng/ml had PTH levels. 50 pg/ml. 6 Also, as observed in our study, the percentage of patients with PTH. 50 ng/ml decreased to 11% for 25OHD levels 35 to 40 ng/ml, and remained at this level for 25OHD levels. 40 ng/ml. 6 Prevention of elevated PTH levels is of clinical importance because investigators have demonstrated that increased levels of PTH are independently associated with an increased risk of fracture and a faster rate of bone density loss. 6,8,10,15-17 Specifically, once PTH levels exceed 50 pg/ml, there is a significant increase in the risk of fracture. 10 Garnero and colleagues 10 reported an 80% increase in the risk of fractures (relative risk, 1.8; 95% CI, ) in postmenopausal women whose PTH levels were. 50 pg/ml. All of these observations have led researchers to question if individuals in the normal population would benefit from 25OHD levels. 30 ng/ml. 5,6,18 In a similar fashion, we assessed 25OHD effect on PTH to help determine the most appropriate minimum goal for 25OHD levels in patients with CF. We specifically sought to determine the 25OHD level at which a clinician could have confidence that PTH is, 50 pg/ml, given its known association with increased risk for bone loss. The most important finding of this study is that a goal 25OHD level 35 ng/ml in a patient with CF provides a clinician with more confidence that his or her patient will not have a PTH level in a range 472 Original Research

5 associated with increased bone loss and risk of fracture. Clinicians can be 90% confident of suppression of PTH levels below 50 pg/ml if 25OHD levels 35 ng/ml are achieved. At 25OHD levels between 30 and 34 ng/ml, approximately 23% of patients with CF will still have PTH levels. 50 pg/ml. These data suggest that future guidelines for treatment of vitamin D deficiency in patients with CF should consider a higher goal 25OHD level. Additionally, results of this study demonstrate that vitamin D2 supplementation can result in correction of elevated PTH levels. There were 82 individuals (37.8%) who initially were vitamin D deficient (25OHD levels 20 ng/ml). Thirty-six of these individuals received sufficient supplementation to improve their 25OHD level 30 ng/ml. This resulted in a statistically significant decrease in PTH levels from pg/ml to pg/ml ( P 5.03). Another lesson from this study is that maintenance of 25OHD levels in the desired range requires close attention and likely an increase in long-term maintenance vitamin D supplementation. In one-half of the individuals whose 25OHD levels were corrected from, 20 to. 30 ng/ml, levels subsequently declined again to, 30 ng/ml the following year, despite ongoing supplementation with at least 800 International Units of vitamin D2 daily. The design of the current study did not allow determination of the exact time course of this decline. This tendency for rapid decline over time may provide further reason to aim for 25OHD levels of 35 ng/ml rather than the current guidelines of 30 ng/ml, as it is clear from previous studies that PTH most rapidly rises when 25OHD levels drop below 30 ng/ml. A total of 84.3% of the patients in our study were pancreatic insufficient, which is similar to the rate found in the CF population nationally. These individuals may require more therapy to maintain vitamin D stores, highlighting the potential importance of recent research suggesting that maintenance therapy with vitamin D3 may be a more effective way of maintaining 25OHD levels in patients with CF. 4 Specifically, many caregivers of patients with CF have begun using daily 2,000 International Units vitamin D3, in addition to vitamin D already found in CF vitamins and diet, to maintain 25OHD levels at goal. Also recently available is 50,000 International Units vitamin D3, which can be given once or twice monthly to help maintain 25OHD levels. Finally, there is a known seasonal variation in 25OHD levels, with levels in the winter and spring more likely to be low. Although 2005 CFF guidelines suggest testing 25OHD levels in the late fall, further research is needed to clarify the optimal monitoring strategy. One potential concern about aiming for higher goal 25OHD levels is the risk of hypervitaminosis D. The highest 25OHD level measured in this study was 99 ng/ml, even with aggressive repletion regimens of vitamin D2 50,000 International Units daily for 30 days. This patient did not demonstrate signs of hypervitaminosis D and had a normal serum calcium level. Vitamin D intoxication is defined as a 25OHD level. 150 ng/ml associated with hypercalcemia, hyperphosphatemia, and hypercalciuria. 5 I t is estimated that 25OHD levels. 150 to 200 ng/ml 5 are required for the development of vitamin D intoxication, an unlikely complication of aiming for a 25OHD level of 35 ng/ml. It is also important to recall that there are pathologic conditions that result in elevated PTH levels independent of vitamin D status. These include primary hyperparathyroidism and renal disease, so the presence of hypercalcemia or PTH levels not consistent with measured 25OHD levels should lead to exploration of other possible contributors. In summary, vitamin D deficiency and decreased bone density are important complications in individuals with CF, and consensus guidelines for optimizing CF bone health have, therefore, been developed. This study suggests that the current recommended guideline of maintaining 25OHD levels 30 ng/ml in patients with CF may still place close to 25% of patients at risk for having elevated PTH levels. Aiming for only a level of 30 ng/ml in patients with CF with its difficult-to-maintain 25OHD levels may also put patients at risk for experiencing the rapid rise in PTH known to occur when 25OHD levels are, 30 ng/ml. Aiming instead to maintain 25OHD levels 35 ng/ml will give the CF clinician greater confidence in reducing PTH levels below the range associated with increased risk of fracture and loss of bone mineral density. Because of the challenge of maintaining 25OHD levels at this level in CF, both close monitoring in individual patients and further research on appropriate chronic vitamin D supplementation are required. Acknowledgments Author contributions: Dr West had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr West: contributed to study concept and design; acquisition, analysis, and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; and administrative, technical, or material support. Dr Lechtzin: contributed to study concept and design; analysis, and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; and administrative, technical, or material support. Dr Merlo: contributed to study concept and design and critical revision of the manuscript for Dr Turowski: contributed to acquisition of data and critical revision of the manuscript for Ms Davis: contributed to critical revision of the manuscript for CHEST / 140 / 2 / AUGUST,

6 Ms Ramsay: contributed to critical revision of the manuscript for Ms Watts : contributed to critical revision of the manuscript for Dr Stenner: contributed to critical revision of the manuscript for Dr Boyle: contributed to study concept and design; analysis, and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; and study supervision. Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Other contributions: We thank Suzanne Jan de Beur, MD, for her insightful commentary in manuscript preparation. The work was performed at Johns Hopkins University.. References 1. Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab ;90(3): Cystic Fibrosis Foundation. Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; October Patient Registry Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med ;172(2): Khazai NB, Judd SE, Jeng L, et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab ;94(6): Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol ; 19 ( 2 ): Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int ;7(5): Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res ;22(suppl 2 ):V100-V Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone ;35 (1 ): Joly D, Drueke TB, Alberti C, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis ; 51 (6 ): Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res ;15 (8 ): Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D- sufficient subjects. J Clin Endocrinol Metab ; 88 ( 8 ): Brown SA, Ontjes DA, Lester GE, et al. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis. Osteoporos Int ;14 (5 ): Harkness L, Cromer B. Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int ;16 (1 ): Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes ;15 (6 ): Meunier PJ, Chapuy MC, Arlot ME, Delmas PD, Duboeuf F. Can we stop bone loss and prevent hip fractures in the elderly? Osteoporos Int ;4 (suppl 1 ): Martínez ME, del Campo MT, Sánchez-Cabezudo MJ, et al. Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int ;55 (4 ): Rosen CJ, Morrison A, Zhou H, et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner ; 25 ( 2 ): Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med ; 338 (12 ): Original Research

The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels

The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels CLINICAL RESEARCH STUDY The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels Walid Saliba, MD, MPH, a Ofra Barnett, PhD, a Hedy S. Rennert, MPH, a Idit Lavi, MA, a Gad Rennert, MD, PhD

More information

Vitamin D. Vitamin functioning as hormone. Todd A Fearer, MD FACP

Vitamin D. Vitamin functioning as hormone. Todd A Fearer, MD FACP Vitamin D Vitamin functioning as hormone Todd A Fearer, MD FACP Vitamin overview Vitamins are organic compounds that are essential in small amounts for normal metabolism They are different from minerals

More information

Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation 1 3

Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation 1 3 Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation 1 3 Alisha J Rovner, Virginia A Stallings, Joan I Schall, Mary B Leonard, and

More information

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014 HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research

More information

Hellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency. Spyridon Karras MD, Phd Endocrinologist

Hellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency. Spyridon Karras MD, Phd Endocrinologist Hellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency Spyridon Karras MD, Phd Endocrinologist Pregnancy We recommend a minimum intake of 600 international units of

More information

Vitamin D Deficiency. Decreases renal calcium excretion. Increases intestinal absorption Calcium. Increases bone resorption of calcium

Vitamin D Deficiency. Decreases renal calcium excretion. Increases intestinal absorption Calcium. Increases bone resorption of calcium Vitamin D Deficiency Deborah Gordish, MD Assistant Professor of Clinical Internal Medicine Lead Physician Lewis Center Primary Care Associate Division Director General Internal Medicine The Ohio State

More information

The Role of the Laboratory in Metabolic Bone Disease

The Role of the Laboratory in Metabolic Bone Disease The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology

More information

Elecsys bone marker panel. Optimal patient management starts in the laboratory

Elecsys bone marker panel. Optimal patient management starts in the laboratory bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Vol 116 No 1179 ISSN 1175 8716 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency Fiona Wu, Toni Staykova, Anne Horne, Judy Clearwater,

More information

Vitamin D & Cardiovascular Disease

Vitamin D & Cardiovascular Disease Vitamin D & Cardiovascular Disease Disclosures None Vitamin D Objectives: Discuss the basics of vitamin D metabolism Discuss the role of vitamin D deficiency in the development of coronary disease Review

More information

Vitamin D and Calcium

Vitamin D and Calcium Vitamin D and Calcium American Association of Clinical Endocrinologists Marina Del Rey, CA September 15, 2018 Albert Shieh, MD MS Assistant Clinical Professor Department of Medicine Division of Endocrinology

More information

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008 BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology

More information

MEDICAL POLICY EFFECTIVE DATE: 08/21/14 REVISED DATE: 04/16/15, 06/16/16, 07/20/17 SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY

MEDICAL POLICY EFFECTIVE DATE: 08/21/14 REVISED DATE: 04/16/15, 06/16/16, 07/20/17 SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY MEDICAL POLICY SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY A nonprofit independent licensee of the BlueCross BlueShield Association PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

Dr Seeta Durvasula.

Dr Seeta Durvasula. Dr Seeta Durvasula seeta.durvasula@sydney.edu.au 1 Avoid sun skin cancer risk Australia has highest rates of skin cancer in the world Epidemic of Vitamin D deficiency Lack of Vitamin D increases risk of

More information

The Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis. Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi

The Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis. Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi The Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi The Sun-Shine Vitamin Vitamin D is unique because it can be synthesized

More information

Endocrine Complications of Cystic Fibrosis. Marisa Desimone MD SUNY Upstate Medical University Syracuse, NY

Endocrine Complications of Cystic Fibrosis. Marisa Desimone MD SUNY Upstate Medical University Syracuse, NY Endocrine Complications of Cystic Fibrosis Marisa Desimone MD SUNY Upstate Medical University Syracuse, NY I have no conflicts of interest to disclose Learning Objectives 1. Review the most common endocrine

More information

Outline. The Role of Vitamin D in CKD. Essential Role of Vitamin D. Mechanism of Action of Vit D. Mechanism of Action of Vit D 7/16/2010

Outline. The Role of Vitamin D in CKD. Essential Role of Vitamin D. Mechanism of Action of Vit D. Mechanism of Action of Vit D 7/16/2010 Outline The Role of Vitamin D in CKD Priscilla How, Pharm.D., BCPS Assistant Professor National University of Singapore Principal Clinical Pharmacist National University Hospital (Pharmacy and Nephrology,

More information

Vitamin D Status of an Outpatient Clinic Population

Vitamin D Status of an Outpatient Clinic Population Calcif Tissue Int (2001) 69:263 267 DOI: 10.1007/s002230010054 2001 Springer-Verlag New York Inc. Vitamin D Status of an Outpatient Clinic Population L. Margiloff, 1 S. S. Harris, 2 S. Lee, 3 R. Lechan,

More information

Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO

Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO Disclosures: (Academic Mea Culpa) No financial conflicts I have no expertise re: Vitamin D. OBJECTIVES: 1) Review

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2018 2/2019 2/2018 Description of Procedure or Service Vitamin D,

More information

Vitamin D. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist

Vitamin D. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist Vitamin D Mrs Sophie Barnes FRCPath Consultant Clinical Scientist Learning objectives Biochemistry and physiology of vitamin D Causes and consequences of vitamin D deficiency Current and anticipated guidelines

More information

Zeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012

Zeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012 A Randomized Open Label Trial to Evaluate the Efficacy of Different Dosage Forms of Vitamin D in Patients with Vitamin D Deficiency, and the Effect of Food on Vitamin D Absorption. Zeenat Ali, PGY3 Joseph

More information

THE SUNSHINE VITAMIN. Maureen Molini, MPH, RDN, CSSD University of Nevada Reno Student Health Services

THE SUNSHINE VITAMIN. Maureen Molini, MPH, RDN, CSSD University of Nevada Reno Student Health Services THE SUNSHINE VITAMIN Maureen Molini, MPH, RDN, CSSD University of Nevada Reno Student Health Services Vitamin vs. Prohormone Technically not a vitamin since it isn t obtained solely through diet Synthesized

More information

The effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome

The effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome CRC IRB Proposal Matthew Champion PGY-1 8/29/12 The effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome Study Purpose

More information

OPTIMISING NUTRITION IN CF ADULTS DR HELEN WHITE

OPTIMISING NUTRITION IN CF ADULTS DR HELEN WHITE OPTIMISING NUTRITION IN CF ADULTS DR HELEN WHITE MULTISYSTEM DISEASE Pancreatic insufficiency Nutritional status CF related diabetes Fat soluble vitamin status Bone health Greater complexity of care in

More information

The Vitamin D Gap. Vitamin D intake guidelines were established to prevent. Estimating an adequate intake of vitamin D. FEATURE VITAMIN D GAP

The Vitamin D Gap. Vitamin D intake guidelines were established to prevent. Estimating an adequate intake of vitamin D. FEATURE VITAMIN D GAP The Vitamin D Gap Estimating an adequate intake of vitamin D. By Laurence Montgomery, ND and George Tardik, ND Vitamin D intake guidelines were established to prevent rickets in children and osteomalacia

More information

Clinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D

Clinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D Clinical Policy: Reference Number: CP.MP.152 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

VITAMIN D AND THE ATHLETE

VITAMIN D AND THE ATHLETE VITAMIN D AND THE ATHLETE CONSIDERATIONS FOR THE PRACTITIONER Written by Bruce Hamilton, Qatar Vitamin D is a steroid hormone that has previously been given little attention, partially as a result of its

More information

Medical Policy Vitamin D Screening and Testing

Medical Policy Vitamin D Screening and Testing Medical Policy Vitamin D Screening and Testing Subject: Vitamin D Screening and Testing Background: Vitamin D is a prohormone that is inactive until converted (in the liver) to 25-hydroxyvitamin D (25[OH]D;

More information

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker

More information

THE IMPORTANCE OF ADEQUATE

THE IMPORTANCE OF ADEQUATE ORIGINAL CONTRIBUTION Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake Laufey Steingrimsdottir, PhD Orvar Gunnarsson, MD Olafur S. Indridason, MD, MHS Leifur

More information

Vitamin D Deficiency. Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver

Vitamin D Deficiency. Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver Vitamin D Deficiency Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver 50 yo woman referred for osteoporosis What is striking about her

More information

Steroid hormone vitamin D: Implications for cardiovascular disease Circulation research. 2018; 122:

Steroid hormone vitamin D: Implications for cardiovascular disease Circulation research. 2018; 122: Steroid hormone vitamin D: Implications for cardiovascular disease Circulation research. 2018; 122:1576-1585 November 20, 2010: Canadian and US government request the Institute of Medicine to provide a

More information

The Skeletal Response to Aging: There s No Bones About It!

The Skeletal Response to Aging: There s No Bones About It! The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium

More information

Copyright information:

Copyright information: A Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.

More information

VITAMIN D IN HEALTH & DISEASE. Boyd C.Hoddinott B Sc, MD, MPH Logan County Health Commissioner

VITAMIN D IN HEALTH & DISEASE. Boyd C.Hoddinott B Sc, MD, MPH Logan County Health Commissioner VITAMIN D IN HEALTH & DISEASE Boyd C.Hoddinott B Sc, MD, MPH Logan County Health Commissioner Summary Foods in North America were fortified with vitamin D to reduce the occurrence of rickets. This appeared

More information

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019 Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal

More information

ESPEN Congress Prague 2007

ESPEN Congress Prague 2007 ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus

More information

Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine

Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine meek.shon@mayo.edu 2016 MFMER 3561772-1 Update on Vitamin D Shon Meek MD, PhD 20 th Annual Endocrine Update January 30-Feb 3, 2017 Disclosure Relevant

More information

V t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s

V t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s Vitamin D and Calcium: Role in Prevention and Treatment of Fractures and Falls Osteoporosis 21: New Insights In Research, Diagnosis, and Clinical Care Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2017 2/2018 2/2017 Description of Procedure or Service Vitamin D,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern

More information

02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis.

02/27/2018. Objectives. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. To Replace or Not to Replace: Nutritional Vitamin D in Dialysis. Michael Shoemaker-Moyle, M.D. Assistant Professor of Clinical Medicine Objectives Review Vitamin D Physiology Review Current Replacement

More information

Vitamin D and Cardiovascular Disease

Vitamin D and Cardiovascular Disease Vitamin D and Cardiovascular Disease Carrie W. Nemerovski, Pharm.D., Michael P. Dorsch, Pharm.D., Robert U. Simpson, Ph.D., Henry G. Bone, M.D., Keith D. Aaronson, M.D., and Barry E. Bleske, Pharm.D.,

More information

Vitamin D Deficiency in Adults: When to Test and How to Treat. Kurt A. Kennel, MD; Matthew T. Drake, MD, PhD; and Daniel L.

Vitamin D Deficiency in Adults: When to Test and How to Treat. Kurt A. Kennel, MD; Matthew T. Drake, MD, PhD; and Daniel L. CONCISE REVIEW FOR CLINICIANS VITAMIN D DEFICIENCY IN ADULTS Vitamin D Deficiency in Adults: When to Test and How to Treat Kurt A. Kennel, MD; Matthew T. Drake, MD, PhD; and Daniel L. Hurley, MD Recent

More information

Research Article Incidence of Fractures after Cardiac and Lung Transplantation: A Single Center Experience

Research Article Incidence of Fractures after Cardiac and Lung Transplantation: A Single Center Experience Osteoporosis, Article ID 573041, 8 pages http://dx.doi.org/10.1155/2014/573041 Research Article Incidence of Fractures after Cardiac and Lung Transplantation: A Single Center Experience Aileen Hariman,

More information

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012 Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco

More information

BMD: A Continuum of Risk WHO Bone Density Criteria

BMD: A Continuum of Risk WHO Bone Density Criteria Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris

More information

Study of secondary causes of male osteoporosis

Study of secondary causes of male osteoporosis Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos

More information

The discovery of Vitamin D and the elimination of rickets has been considered as one of Medicine s Greatest Achievements.

The discovery of Vitamin D and the elimination of rickets has been considered as one of Medicine s Greatest Achievements. The discovery of Vitamin D and the elimination of rickets has been considered as one of Medicine s Greatest Achievements. SIR EDWARD MELLANBY 1 8 8 4-1 9 5 5 A D I E T C H A R A C T E R I S T I C O F S

More information

FOCUS ON CARDIOVASCULAR DISEASE

FOCUS ON CARDIOVASCULAR DISEASE The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.

More information

Vitamin D: Is it a superhero??

Vitamin D: Is it a superhero?? Vitamin D: Is it a superhero?? Dr. Ashraf Abdel Basset Bakr Prof. of Pediatrics 1 2 History of vitamin D discovery Sources of vitamin D and its metabolism 13 Actions of vitamin D 4 Vitamin D deficiency

More information

Vitamin D and Calcium Therapy: how much is enough

Vitamin D and Calcium Therapy: how much is enough Vitamin D and Calcium Therapy: how much is enough Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco DISCLOSURE Nothing to disclose 1 RECOMMENDATIONS

More information

Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management

Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management There is growing interest in the importance

More information

The Endocrine Society Guidelines

The Endocrine Society Guidelines Vitamin D and Calcium Therapy: how much is enough DISCLOSURE Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco Nothing to disclose RECOMMENDATIONS

More information

Current Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012.

Current Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012. Current Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012 Disclosures I have no financial relationships with commercial interests,

More information

Managing Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018

Managing Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Managing Endocrine Related Issues after Bariatric Surgery Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Bariatric Surgery was Associated with Higher Remission Rate than Usual Care 72.3% 38.1%

More information

Vitamin D Supplementation for Pain

Vitamin D Supplementation for Pain Vitamin D Supplementation for Pain Christan M. Thomas, PharmD; Peter Campbell, PharmD US Pharmacist. 2015;40(3):43 46. www.medscape.com Abstract and Introduction Abstract Vitamin D, a fat soluble vitamin

More information

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients A. WADGYMAR, MD Credit Valley Hospital, Mississauga, Ontario, Canada. June 1, 2007 1 Case: 22 y/o referred to Renal Clinic Case: A.M. 29 y/o Man

More information

original Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2)

original Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2) Endocrine Journal 2014, 61 (12), 1197-1204 original Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National Health and Nutrition Examination

More information

Bone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017

Bone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017 Bone Health in Celiac Disease Partha S. Sinha MD, PhD October 29 th, 2017 No Disclosures Objectives Recognize the mechanisms by which celiac disease can affect bone health Review what diagnostic tests

More information

VITAMIN D IN HEALTH AND DISEASE

VITAMIN D IN HEALTH AND DISEASE VITAMIN D IN HEALTH AND DISEASE Margus Lember University of Tartu, Estonia ESIM, Saas Fee, January 16, 2014 l It`s most healthy to live on the southern side of a mountain l Hippokrates of Kos 460-370 BC

More information

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study ISPUB.COM The Internet Journal of Nutrition and Wellness Volume 12 Number 1 Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University S Shukar-ud-din, R Tabassum,

More information

VITAMIN D TESTING CLINICAL GUIDELINES. Policy Number: PDS Effective Date: January 1, Table of Contents

VITAMIN D TESTING CLINICAL GUIDELINES. Policy Number: PDS Effective Date: January 1, Table of Contents CLINICAL GUIDELINES VITAMIN D TESTING Policy Number: PDS - 010 Effective Date: January 1, 2013 Table of Contents Page Guidelines 1 BACKGROUND 3 CLINICAL EVIDENCE 5 U.S. FOOD AND DRUG ADMINISTRATION (FDA)

More information

J Korean Soc Spine Surg 2016 Mar;23(1): Originally published online March 31, 2016;

J Korean Soc Spine Surg 2016 Mar;23(1): Originally published online March 31, 2016; Journal of Korean Society of Spine Surgery The Association of Low-energy Spine Fractures and Vitamin D Inadequacy: A Case-control Study Jaewon Lee, M.D., Wan-Sik Seo, M.D., Byung-Jik Kang, M.D., Joon-kuk

More information

CYSTIC FIBROSIS (CF) COMPLICATIONS BEYOND THE LUNGS. A Resource for the CF Center Care Team

CYSTIC FIBROSIS (CF) COMPLICATIONS BEYOND THE LUNGS. A Resource for the CF Center Care Team CYSTIC FIBROSIS (CF) COMPLICATIONS BEYOND THE LUNGS A Resource for the CF Center Care Team Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210. Vertex and the Vertex triangle logo

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Prevalence and Pattern of Mineral Bone Disorder in Chronic Kidney Disease Patients Using Serum

More information

Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior

Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior J. Endocrinol. Invest. 28: 180-182, 2005. OPINION Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior R.P. Heaney Creighton University, Omaha, Nebraska,USA Most reported studies

More information

The hart and bone in concert

The hart and bone in concert The hart and bone in concert Piotr Rozentryt III Department of Cardiology, Silesian Centre for Heart Disease, Silesian Medical University, Zabrze, Poland Disclosure Research grant, speaker`s fee, travel

More information

DBC 25-Hydroxyvitamin D

DBC 25-Hydroxyvitamin D D I A G N O S T I C S B I O C H E M C A N A D A DBC 25-Hydroxyvitamin D ELISA OVERVIEW The worldwide aging and chronically ill population is increasing rapidly. It is forecasted that the Global Vitamin

More information

Original Article. Elizabeth Kos, MD 1 ; Mary Jo Liszek, MD 2 ; Mary Ann Emanuele, MD 3 ; Ramon Durazo-Arvizu, PhD 4 ; Pauline Camacho, MD, FACE 3

Original Article. Elizabeth Kos, MD 1 ; Mary Jo Liszek, MD 2 ; Mary Ann Emanuele, MD 3 ; Ramon Durazo-Arvizu, PhD 4 ; Pauline Camacho, MD, FACE 3 Original Article Elizabeth Kos, MD 1 ; Mary Jo Liszek, MD 2 ; Mary Ann Emanuele, MD 3 ; Ramon Durazo-Arvizu, PhD 4 ; Pauline Camacho, MD, FACE 3 ABSTRACT Objective: To determine the effect of metformin

More information

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone

More information

Alex Chin. Opinion Letter VITAMIN D ANA. Dr. Alex Chin T2L 2K8. in laboratory

Alex Chin. Opinion Letter VITAMIN D ANA. Dr. Alex Chin T2L 2K8. in laboratory Vitamin D Analyte of thee Millennium OPINION LETTER VITAMIN Alex Chin D ANA Calgary Laboratory Services, Calgary, Alberta Canadaa & Department of Pathology and Laboratory Medicine, University of Calgary,

More information

Corporate Presentation January 2013

Corporate Presentation January 2013 Corporate Presentation January 2013 0 Forward-Looking Statements Certain statements and information included in this presentation are forwardlooking statements under the Private Securities Litigation Reform

More information

Clinical Policy: Vitamin D Screening Reference Number: CP.MP.HN499

Clinical Policy: Vitamin D Screening Reference Number: CP.MP.HN499 Clinical Policy: Vitamin D Screening Reference Number: CP.MP.HN499 Effective Date: 12/09 Last Review Date: 7/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Calcium and Vitamin D Supplementation is an Ineffective Strategy for the Prevention of Fractures in Older People

Calcium and Vitamin D Supplementation is an Ineffective Strategy for the Prevention of Fractures in Older People Calcium and Vitamin D Supplementation is an Ineffective Strategy for the Prevention of Fractures in Older People For the Motion: Professor Roger Francis, Institute for Ageing and Health, Newcastle University,

More information

chapter 1 & 2009 KDIGO

chapter 1 & 2009 KDIGO http://www.kidney-international.org chapter 1 & 2009 DIGO Chapter 1: Introduction and definition of CD MBD and the development of the guideline statements idney International (2009) 76 (Suppl 113), S3

More information

Vitamin D Deficiency in the United States: How Common is it?

Vitamin D Deficiency in the United States: How Common is it? Utah State University DigitalCommons@USU Undergraduate Honors Theses Honors Program 5-2010 Vitamin D Deficiency in the United States: How Common is it? Christine N. Arnold Utah State University Follow

More information

THE EFFECT OF A 12-MONTH WEIGHT LOSS INTERVENTION ON VITAMIN D STATUS IN SEVERELY OBESE CAUCASIANS AND AFRICAN AMERICAN ADULTS. Krista Lee Rompolski

THE EFFECT OF A 12-MONTH WEIGHT LOSS INTERVENTION ON VITAMIN D STATUS IN SEVERELY OBESE CAUCASIANS AND AFRICAN AMERICAN ADULTS. Krista Lee Rompolski THE EFFECT OF A 12-MONTH WEIGHT LOSS INTERVENTION ON VITAMIN D STATUS IN SEVERELY OBESE CAUCASIANS AND AFRICAN AMERICAN ADULTS by Krista Lee Rompolski B.S. Exercise Science, Bloomsburg University of Pennsylvania,

More information

Disclosure 7/2/2018. Consultant : Ultragenyx, Alexion, Ferrings. Research grant support: Ultragenyx, Shire, Amgen. Clinical Trial : Ultragynyx, Amgen

Disclosure 7/2/2018. Consultant : Ultragenyx, Alexion, Ferrings. Research grant support: Ultragenyx, Shire, Amgen. Clinical Trial : Ultragynyx, Amgen Pisit (Duke) Pitukcheewanont, MD, FAAP Clinical Director, Pediatric Bone Program, Center for Diabetes, Endocrinology & Metabolism Children s Hospital Los Angeles Professor of Clinical Pediatrics The Keck

More information

VITAMIN D IS REQUIRED FOR EFficient

VITAMIN D IS REQUIRED FOR EFficient ORIGINAL CONTRIBUTION Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Meryl S. LeBoff, MD Lynn Kohlmeier, MD Shelley Hurwitz, PhD Jennifer Franklin John Wright, MD Julie Glowacki,

More information

Bone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases

Bone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral

More information

Association between Seasonal Changes in Vitamin D and Bone Mineral Density

Association between Seasonal Changes in Vitamin D and Bone Mineral Density 대한폐경학회지제 17 권제 2 호 2011 Vol. 17, No. 2, August. 2011 Association between Seasonal Changes in Vitamin D and Bone Mineral Density Department of Family Practice and Community Health, Ajou University School

More information

APPLIED NUTRITIONAL INVESTIGATION INTRODUCTION

APPLIED NUTRITIONAL INVESTIGATION INTRODUCTION APPLIED NUTRITIONAL INVESTIGATION Low Serum Concentrations of 25-Hydroxyvitamin D in Young Adult Japanese Women: A Cross Sectional Study Kazutoshi Nakamura, MD, MPH, Mitsue Nashimoto, BA, Shigeki Matsuyama,

More information

Calcium metabolism and the Parathyroid Glands. Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands

Calcium metabolism and the Parathyroid Glands. Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands Calcium metabolism and the Parathyroid Glands Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands Calcium is an essential element for contraction of voluntary/smooth

More information

Parathyroid hormone (serum, plasma)

Parathyroid hormone (serum, plasma) Parathyroid hormone (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Parathyroid hormone (PTH) 1.2 Alternative names Parathormone 1.3 NMLC code 1.4 Description of analyte PTH is an

More information

Diabetes Care Publish Ahead of Print, published online October 21, 2009

Diabetes Care Publish Ahead of Print, published online October 21, 2009 Diabetes Care Publish Ahead of Print, published online October 21, 2009 Vitamin D, Parathyroid Hormone and Insulin Resistance Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD

Calcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:

More information

Supplementary Information to Chapter 36

Supplementary Information to Chapter 36 REVIEW ON VITAMIN-D NEW INSIGHTS Elmer Verner McCollum (1879-1967) was the first to discover the antirachitic vitamin which he named as vitamin D in the early part of 20th century (1919). He had earlier

More information

Welcome to mmlearn.org

Welcome to mmlearn.org Welcome to mmlearn.org VITAMIN D SUNSHINE VITAMIN INTRODUCTION Familiar with skeletal needs Rickets Osteoporosis Fractures INTRODUCTION Not as familiar other associations Immune system Cancer Cardiovascular

More information

The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S

The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

An audit of osteoporotic patients in an Australian general practice

An audit of osteoporotic patients in an Australian general practice professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to

More information

Sensipar. Sensipar (cinacalcet) Description

Sensipar. Sensipar (cinacalcet) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.46 Subject: Sensipar Page: 1 of 5 Last Review Date: June 22, 2018 Sensipar Description Sensipar (cinacalcet)

More information

JMSCR Vol 06 Issue 12 Page December 2018

JMSCR Vol 06 Issue 12 Page December 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.157 A comparative study of two

More information

VITAMIN D STATUS OF AMERICAN ADULTS AGE 18 YEARS AND OLDER: NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY and Kayla K.

VITAMIN D STATUS OF AMERICAN ADULTS AGE 18 YEARS AND OLDER: NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY and Kayla K. VITAMIN D STATUS OF AMERICAN ADULTS AGE 18 YEARS AND OLDER: NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2001-2002 and 2003-2004 Kayla K. Scherf A Thesis Submitted to the Graduate College of Bowling

More information

DM and Osteoporosis. Why is it important?

DM and Osteoporosis. Why is it important? DM and Osteoporosis Why is it important? Diabetes Osteoporosis Fractures Dr Pedro Conthe HGUGM Madrid Spain Agenda: DM and Osteoporosis Observational studies Physiopathology of bone Type I and Type 2 DM

More information

Evidence Synthesis Number 118. Screening for Vitamin D Deficiency: Systematic Review for the U.S. Preventive Services Task Force Recommendation

Evidence Synthesis Number 118. Screening for Vitamin D Deficiency: Systematic Review for the U.S. Preventive Services Task Force Recommendation Evidence Synthesis Number 118 Screening for Vitamin D Deficiency: Systematic Review for the U.S. Preventive Services Task Force Recommendation Prepared for: Agency for Healthcare Research and Quality U.S.

More information

Malnutrition and Role of Nutrition in BMD:CKD

Malnutrition and Role of Nutrition in BMD:CKD Malnutrition and Role of Nutrition in BMD:CKD PNDS Continuing Nutrition Education Seminar Saturday, 30 th November 2013 Fayza Khan MSC (Foods and Nutrition) R.D President,PNDS Outline Objective Malnutrition

More information